42880-33-1Relevant articles and documents
-
Maley,Plaut
, p. 2025 (1959)
-
-
Karrer et al.
, p. 426,427, 1435, 1447 (1935)
-
Reduction of Hg(II)·EDTA by conformationally biased flavins
Hasford, Justin J.,Rizzo, Carmelo J.
, p. 1317 - 1320 (1998)
The rates of Hg(II)·EDTA reduction by conformationally biased flavins are reported. The rates of the reduction correlate to the redox potential of the flavin model. In the case of 8,9,10-trimethylflavin (6), the rate was slower than expected from the redox potential.
Oxygen reactivity in flavoenzymes: Context matters
McDonald, Claudia A.,Fagan, Rebecca L.,Collard, Francois,Monnier, Vincent M.,Palfey, Bruce A.
, p. 16809 - 16811 (2011)
Many flavoenzymes-oxidases and monooxygenases-react faster with oxygen than free flavins do. There are many ideas on how enzymes cause this. Recent work has focused on the importance of a positive charge near N5 of the reduced flavin. Fructosamine oxidase has a lysine near N5 of its flavin. We measured a rate constant of 1.6 × 105 M-1 s-1 for its reaction with oxygen. The Lys276Met mutant reacted with a rate constant of 291 M-1 s-1, suggesting an important role for this lysine in oxygen activation. The dihydroorotate dehydrogenases from E. coli and L. lactis also have a lysine near N5 of the flavin. They react with O2 with rate constants of 6.2 × 104 and 3.0 × 103 M-1 s-1, respectively. The Lys66Met and Lys43Met mutant enzymes react with rate constants that are nearly the same as those for the wild-type enzymes, demonstrating that simply placing a positive charge near N5 of the flavin does not guarantee increased oxygen reactivity. Our results show that the lysine near N5 does not exert an effect without an appropriate context; evolution did not find only one mechanism for activating the reaction of flavins with O2.
Studies on the reaction between reduced riboflavin and selenocystine
Dereven'kov, Ilia A.,Makarov, Sergei V.,Molodtsov, Pavel A.,Makarova, Anna S.
, p. 146 - 153 (2020/09/21)
Selenocysteine (Sec) is a crucial component of mammalian thioredoxin reductase (TrxR) where it serves as a nucleophile for disulfide bond rupture in thioredoxin (Trx). Generation of the reduced state of Sec in TrxR requires consecutive two electron transfer steps, namely: (i) from NADPH to flavin adenine dinucleotide, (ii) from reduced flavin to the disulfide bond Cys59-S-S-Cys64, and finally (iii) from Cys59 and Cys64 to the selenosulfide bond Cys497-S-Se-Sec498. In this work, we studied the reaction between reduced riboflavin (RibH2) and selenocystine (Sec-Sec), an oxidized form of Sec. The interaction between RibH2 and Sec-Sec proceeded relatively slowly in comparison with its reverse reaction, that is, reduction of riboflavin (Rib) by Sec. The rate constant for the reaction between RibH2 and Sec-Sec was (7.9?±?0.1)?×?10?2?M?1 s?1 (pH 7.0, 25.0°C). The reaction between Rib and Sec proceeded via two steps, namely, a rapid reversible binding of Rib to Sec having a protonated selenol group to form a Sec-Rib complex, followed by nucleophilic attack of Sec-Rib by a second Sec molecule harboring a deprotonated selenol group. The equilibrium constant for the overall reduction process of Rib by Sec is (1.2?±?0.1)?×?106?M?1 (25.0°C). The finding that the interaction of RibH2 with oxidized selenol is reversible with its equilibrium favored toward the reverse reaction provides an additional explanation for the exceptional mechanism of the mammalian Trx/TrxR system involving transient reduction of a disulfide bond.
Single label comparative hybridization
-
, (2015/01/06)
The present invention provides methods of detecting and mapping chromosomal or genetic abnormalities associated with various diseases or with predisposition to various diseases, or to detecting the phenomena of large scale copy number variants. In particular, the present invention provides advanced methods of performing array-based comparative hybridization that allow reproducibility between samples and enhanced sensitivity by using the same detectable label for both test sample and reference sample nucleic acids. Invention methods are useful for the detection or diagnosis of particular disease conditions such as cancer, and detecting predisposition to cancer based on detection of chromosomal or genetic abnormalities and gene expression level. Invention methods are also useful for the detection or diagnosis of hereditary genetic disorders or predisposition thereto, especially in prenatal samples. Moreover, invention methods are also useful for the detection or diagnosis of de novo genetic aberrations associated with post-natal developmental abnormalities.
